SABS (SAB Biotherapeutics Inc.) Net Profit

SABS (SAB Biotherapeutics, Inc.) - company brandmark

The stable operation of bioreactors with updated filtration has laid the foundation for the development of SAB Biotherapeutics. Today, the company's net income, as shown on the summary chart at GURU.Markets, stands at -0.04, which helps distinguish real growth from speculation. Prospects rely on the DiversitAb platform to forge long-term alliances with pharma behemoths and the use of transgenic cows for accelerated antibody synthesis.

SABS (SAB Biotherapeutics) Net Profit history from 07/04/2022 to 10/30/2026
Core merchandise of SAB Biotherapeutics, Inc

Net income, equal to -0.04, reflects the final financial result after deducting all operating and tax expenses, allowing for an assessment of the business's actual profitability. By analyzing the net income trends of SAB Biotherapeutics (SABS), an investor can diagnose the financial stability of SAB Biotherapeutics, which currently depends critically on the outcome of clinical trials and the costly production of antibodies.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|PGEN - Company Net Income|Net Financial Result Pharming Corp PHAR|NKTR: Net Profit|upstreambio.com (UPB) - Net Profit|ZBIO (Zenas Biopharma) - Net Profit|Company Net Income IMNM|Net Income GOSS (Gossamer Corp)|KALV (KalVista Corp) - Final Profit|Net Profit SEPN (Septerna Inc)|pieris.com - Company Net Income|Savara - Net Profit|Net Financial Result Rigel Pharma RIGL|AnaptysBio Corp (ANAB) - Company Net Income|Company Net Income Astria Corp (ATXS)|Net Income ENGN|RAPT (rapt.com) - Profit After Payment of Taxes|Net Profit JBIO|ACRS (Aclaris Therapeutics Inc.) - Final Profit|Net Profit KYTX (Kyverna)|Tiziana Life Sciences, Ltd. (TLSA) - Company Net Income|CABA - Company Net Income|Final Profit VTYX (ventyxbio.com)|THTX: Net Profit|Avalo Therapeutics, Inc. (AVTX) - Net Profit|Company Net Income Eledon|Agenus, Inc - Profit After Tax|Net Profit CLYM|ZURA - Company Net Income|aTyr Pharma - Net Income|Net Profit Adagene Inc ADAG|IMA: Net Income|Shattuck Labs, Inc. - Profit After Payment of Taxes|EQ: Net Profit|CNTB - Net Financial Result|IMUX (Immunic Therapeutics) - Net Profit|Net Income Atara Biotherapeutics Inc (ATRA)|Company Net Income InflaRx N.V. (IFRX)|Net Financial Result X4 Pharmaceuticals, Inc|Company Net Income Adicet Bio, Inc. ACET|Net Financial Result Celularity Inc (CELU)|INmune Bio - Net Profit|BRNS - Net Profit|KZR: Net Profit|AKTX (Akari Therapeutics, Plc) - Company Net Income|Company Net Income Enlivex Therapeutics Ltd|Q32 Bio Corp (QTTB) - Net Financial Result|Company Net Income GeoVax (GOVX)|EDSA: Profit After Tax|Net Profit IBIO (iBio Corp)|Final Profit CARM|XTL Biopharmaceuticals - Net Profit|BOLT - Net Profit|hcwbiologics.com (HCWB) - Company Net Income|Aptevo Therapeutics Inc. - Final Profit|Company Net Income AIM ImmunoTech|Net Income Aditxt Corp (ADTX)|Net Profit GRI|Net Profit xortx.com (XRTX)|Vyome Holdings - Net Income|Final Profit REVB|Indaptus - Net Profit|Net Financial Result BiondVax Pharmaceuticals SCNI|calcimedica.com (CALI) - Company Net Income|Net Income Affimed N.V.|Company Net Income Allakos Inc|Net Income HOOKIPA (HOOK)|Net Income IGMS (IGM Biosciences, Inc.)|Net Profit iTeos Pharma (ITOS)|Company Net Income Ocean Biomedical, Inc. OCEA|TCBP: Company Profit|Third Harmonic Bio, Inc. - Net Profit